Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bone cancer, Sarcoma, Secondary cancers
Closed
Phase 2
This trial is for people with chordoma that has come back or spread to another part of the body (advanced chordoma).
Everyone taking part has receptors for a protein called epidermal growth factor (EGFR positive) on the surface of their cancer cells.
Recruitment start: 27 March 2019
Recruitment end: 2 October 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sandra Strauss
Boehringer Ingelheim
Leiden University Medical Center
University College London Hospital NHS Foundation Trust
Last reviewed: 03 Oct 2022
CRUK internal database number: 15512